Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial.

Maia E VanDyke Allen F MoreyKarl CoutinhoKaiser J RobertsonRichard D'AnnaKent ChevliChristopher H CantrillMichael J EhlertAlexis E TeJeffrey DannJessica M DeLongRamón VirasoroJudith C HagedornRichard LevinEuclid DeSouzaDavid DiMarcoBrad A EricksonCarl OlssonSean P Elliott

Published in: BJUI compass (2023)

The Optilume DCB shows sustained improvement in both objective and subjective voiding parameters at 2-year follow-up. Optilume appears to provide a safe and effective endoscopic treatment alternative for short recurrent anterior urethral strictures among men who wish to avoid or delay formal urethroplasty.

Keyphrases

urinary incontinence
study protocol
ultrasound guided
phase iii
endoscopic submucosal dissection
emergency department
physical activity
replacement therapy
drug induced